AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Myrexis, Inc.

$0 +$0.00 (+100.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0.01
Year Range
$0$0.01
Market Cap
27.58K
AVG Volume
12.47K
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
050K100K150K200K10 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
MYRX Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
12 Q40
12 Q30
12 Q20
12 Q10
11 Q40
11 Q30
11 Q255K
11 Q178K
10 Q4185K
10 Q3185K
Net Income (USD) · TTM
-40M-30M-20M-10M010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
MYRX Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
12 Q4-11.62M
12 Q3-15.89M
12 Q2-23.34M
12 Q1-26.04M
11 Q4-31.21M
11 Q3-34.78M
11 Q2-36.93M
11 Q1-37.28M
10 Q4-38.71M
10 Q3-38.52M
Operating Income (USD) · TTM
-60M-40M-20M010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
MYRX Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
12 Q4-11.99M
12 Q3-16.52M
12 Q2-24.13M
12 Q1-26.89M
11 Q4-31.8M
11 Q3-34.11M
11 Q2-36.26M
11 Q1-37.87M
10 Q4-39.35M
10 Q3-40.18M
EBITDA (USD) · TTM
-40M-30M-20M-10M010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
MYRX EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
12 Q4-11.97M
12 Q3-11.97M
12 Q2-11.22M
12 Q1-11.22M
11 Q4-10.85M
11 Q3-15.37M
11 Q2-23.56M
11 Q1-26.54M
10 Q4-31.45M
10 Q3-32.39M
Cash Flows (USD) · TTM
-40M-30M-20M-10M010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
MYRX Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
12 Q4-12.97M
12 Q3-19.84M
12 Q2-24.89M
12 Q1-26M
11 Q4-27.83M
11 Q3-29.32M
11 Q2-31.46M
11 Q1-31.66M
10 Q4-33.55M
10 Q3-33.1M
EPS (USD) · TTM
-2-1.5-1-0.5010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
MYRX EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
12 Q4-0.43
12 Q3-0.43
12 Q2-0.72
12 Q1-0.83
11 Q4-1.03
11 Q3-1.33
11 Q2-1.43
11 Q1-1.45
10 Q4-1.52
10 Q3-1.52
Expenses (USD) · TTM
020M40M60MR&DSG&ACapex10 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
MYRX Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
12 Q411.99M
12 Q316.52M
12 Q224.16M
12 Q126.94M
11 Q431.86M
11 Q334.17M
11 Q236.39M
11 Q138.01M
10 Q439.63M
10 Q341.42M
Shares Outstanding · TTM
-6M-4M-2M010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
MYRX Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
12 Q4-365K
12 Q3-581K
12 Q2-839K
12 Q1-1.2M
11 Q4-1.51M
11 Q3-2.27M
11 Q2-3.07M
11 Q1-3.88M
10 Q4-4.83M
10 Q3-4.89M
Dividends (USD)
01234Feb 13
MYRX Dividends (USD) by quarter
PeriodDividends (USD)
Feb 132.86
Free Cash Flow Yield
-600000%-400000%-200000%0%med -54236.21%Jan 25May 25Sep 25Jan 26May 26Sep 26
MYRX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-54236.21%
Sep 26-54236.21%
Aug 26-54236.21%
Aug 26-54236.21%
Aug 26-39444.52%
Aug 26-43388.97%
Jul 26-7231.49%
Jul 26-6198.42%
Jul 26-54236.21%
Jul 26-54236.21%
Jul 26-54236.21%
Jun 26-54236.21%
Jun 26-54236.21%
Jun 26-54236.21%
Jun 26-54236.21%
May 26-54236.21%
May 26-48209.97%
May 26-48209.97%
May 26-48209.97%
May 26-108472.42%
Apr 26-72314.94%
Apr 26-72314.94%
Apr 26-72314.94%
Apr 26-72314.94%
Mar 26-72314.94%
Mar 26-72314.94%
Mar 26-72314.94%
Mar 26-72314.94%
Feb 26-72314.95%
Feb 26-108472.42%
Feb 26-108472.42%
Feb 26-108472.42%
Jan 26-108472.42%
Jan 26-108472.42%
Jan 26-108472.42%
Jan 26-108472.42%
Jan 26-108472.42%
Dec 25-108472.42%
Dec 25-108472.42%
Dec 25-433889.7%
Dec 25-86777.94%
Nov 25-144629.89%
Nov 25-144629.89%
Nov 25-144629.89%
Nov 25-144629.89%
Oct 25-144629.89%
Oct 25-144629.89%
Oct 25-144629.89%
Oct 25-8677.79%
Oct 25-8677.79%
Sep 25-14462.99%
Sep 25-216944.85%
Sep 25-216944.85%
Sep 25-144629.89%
Aug 25-216944.85%
Aug 25-216944.85%
Aug 25-216944.85%
Aug 25-216944.85%
Aug 25-216944.84%
Jul 25-216944.85%
Jul 25-216944.85%
Jul 25-216944.85%
Jul 25-216944.85%
Jun 25-216944.85%
Jun 25-216944.85%
Jun 25-216944.85%
Jun 25-433889.7%
May 25-6574.09%
May 25-6198.42%
May 25-6198.42%
May 25-6198.42%
May 25-6198.42%
Apr 25-6198.42%
Apr 25-6198.42%
Apr 25-6198.42%
Apr 25-6198.42%
Mar 25-6198.42%
Mar 25-6198.42%
Mar 25-6198.42%
Mar 25-6198.42%
Feb 25-6198.42%
Feb 25-6198.42%
Feb 25-5423.62%
Feb 25-6198.42%
Jan 25-6198.42%
Jan 25-6198.42%
Jan 25-6198.42%
Jan 25-6198.42%
Jan 25-6198.42%
Dec 24-6198.42%
Dec 24-6198.42%
Dec 24-6198.42%
Dec 24-6198.42%
Nov 24-6198.42%
Nov 24-6198.42%
Nov 24-6111.12%
Nov 24-6198.42%
Nov 24-6198.42%
Oct 24-6198.42%
Oct 24-6198.42%
Price to Sales
050010001500med 702.74Oct 10Jan 11Apr 11Aug 11Nov 11Mar 12Jun 12
MYRX Price to Sales by quarter
PeriodPrice to Sales
Jun 121159.82
Jun 121116.86
Jun 121145.5
Jun 121140.73
May 121178.91
May 121226.64
May 121312.55
May 121441.42
Apr 121450.96
Apr 121460.51
Apr 121489.15
Apr 121450.96
Mar 121446.19
Mar 121023.02
Mar 121083.2
Mar 121033.05
Mar 121056.45
Feb 121083.2
Feb 121096.57
Feb 12939.44
Feb 12922.72
Jan 12926.07
Jan 12912.7
Jan 12882.61
Jan 12902.67
Dec 11895.98
Dec 11390.41
Dec 11379.26
Dec 11389.02
Dec 11380.65
Nov 11349.98
Nov 11347.19
Nov 11370.89
Nov 11375.07
Oct 11390.41
Oct 11389.02
Oct 11384.83
Oct 11383.44
Sep 11382.04
Sep 11387.54
Sep 11402.76
Sep 11395.84
Sep 11383.38
Aug 11376.46
Aug 11383.38
Aug 11399.99
Aug 11401.38
Jul 11469.19
Jul 11480.27
Jul 11494.11
Jul 11498.26
Jul 11480.27
Jun 11571.71
Jun 11582.8
Jun 11597.05
Jun 11650.9
May 11657.23
May 11642.98
May 11685.74
May 11669.9
Apr 11669.9
Apr 11688.9
Apr 11658.81
Apr 11666.73
Apr 11609.72
Mar 11701.82
Mar 11705.5
Mar 11699.98
Mar 11703.66
Feb 11709.19
Feb 11727.61
Feb 11744.19
Feb 11753.4
Jan 11731.29
Jan 11747.87
Jan 11775.5
Jan 11758.92
Dec 10766.29
Dec 101120.07
Dec 101053.7
Dec 101061.99
Dec 101039.87
Nov 101034.34
Nov 101026.04
Nov 101003.92
Nov 101017.74
Oct 101014.98
Oct 101034.34
Oct 101067.53
Oct 101086.89
Oct 101042.64
Sep 10197.03
Sep 10194.99
Sep 10197.03
Sep 10197.54
Aug 10194.99
Aug 10189.37
Aug 10189.88
Aug 10194.99
Jul 10195.5
Price/Operating Cashflow
8101214med 10.08Jul 09Jul 09Jul 09Aug 09Aug 09Sep 09Sep 09
MYRX Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 0912.21
Sep 0913.78
Sep 0910.14
Sep 099.26
Aug 099.59
Aug 0910.29
Aug 0910.14
Aug 099.82
Jul 0910.2
Jul 0910.08
Jul 099.38
Jul 098.82
Jul 098.71
Price to Book
00.10.20.3med 0.02Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
MYRX Price to Book by quarter
PeriodPrice to Book
Sep 260.02
Sep 260.02
Aug 260.02
Aug 260.02
Aug 260.03
Aug 260.03
Jul 260.15
Jul 260.18
Jul 260.02
Jul 260.02
Jul 260.02
Jun 260.02
Jun 260.02
Jun 260.02
Jun 260.02
May 260.02
May 260.02
May 260.02
May 260.02
May 260.01
Apr 260.02
Apr 260.02
Apr 260.02
Apr 260.02
Mar 260.02
Mar 260.02
Mar 260.02
Mar 260.02
Feb 260.02
Feb 260.01
Feb 260.01
Feb 260.01
Jan 260.01
Jan 260.01
Jan 260.01
Jan 260.01
Jan 260.01
Dec 250.01
Dec 250.01
Dec 250
Dec 250.01
Nov 250.01
Nov 250.01
Nov 250.01
Nov 250.01
Oct 250.01
Oct 250.01
Oct 250.01
Oct 250.13
Oct 250.13
Sep 250.08
Sep 250.01
Sep 250.01
Sep 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Aug 250.01
Jul 250.01
Jul 250.01
Jul 250.01
Jul 250.01
Jun 250.01
Jun 250.01
Jun 250.01
Jun 250
May 250.17
May 250.18
May 250.18
May 250.18
May 250.18
Apr 250.18
Apr 250.18
Apr 250.18
Apr 250.18
Mar 250.18
Mar 250.18
Mar 250.18
Mar 250.18
Feb 250.18
Feb 250.18
Feb 250.21
Feb 250.18
Jan 250.18
Jan 250.18
Jan 250.18
Jan 250.18
Jan 250.18
Dec 240.18
Dec 240.18
Dec 240.18
Dec 240.18
Nov 240.18
Nov 240.18
Nov 240.18
Nov 240.18
Nov 240.18
Oct 240.18
Oct 240.18
Myrexis, Inc.
MYRX
Stockpicker

Video analysis: MYRX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.